Lower Bladder Toxicity of Salvage Versus Adjuvant Modern Radiotherapy for Prostate Cancer Patients
Open Access
- 27 April 2022
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 36 (3) , 1375-1382
Abstract
Background/Aim: In prostate cancer, postoperative radiotherapy timing is debated to avoid overtreatments and toxicities. This study compared acute and late rectal and bladder toxicities in the adjuvant and salvage setting. Patients and Methods: In total, 129 patients were analyzed in two groups: adjuvant radiotherapy (aRT) and salvage radiotherapy (sRT). Results: In aRT and sRT, grade 1 (G1) acute bladder toxicities were detected in 40 and 30 patients, and grade 2 (G2) in 1 and 6; G1 late bladder toxicities were described in 30 and 20, and G2 in 6 and 2, respectively. In aRT and sRT, acute G1 rectal toxicities were reported in 18 and 27 patients, and G2 in 5 and 4, respectively. Late rectal G1 toxicities were observed in 10 patients, G2 in 6 and G3 in 1 in the aRT. In sRT, 8 patients and 1 developed G1 and G2 toxicities, respectively. Regarding bladder toxicity, a higher incidence occurred in aRT; late toxicity was lower in sRT. Conclusion: Adjuvant and salvage RT in prostate cancer treatment resulted in acceptable toxicities.Keywords
This publication has 34 references indexed in Scilit:
- Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancerJournal of Cancer Research and Clinical Oncology, 2012
- Clinical Factors Predicting Late Severe Urinary Toxicity After Postoperative Radiotherapy for Prostate Carcinoma: A Single-Institute Analysis of 742 PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Toxicity Analysis of Postoperative Image-Guided Intensity-Modulated Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95Journal of Clinical Oncology, 2009
- Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical TrialJournal of Urology, 2009
- Analysis of Gastrointestinal and Genitourinary Morbidity of Postoperative Radiotherapy for Pathologic T3 Disease or Positive Surgical Margins After Radical Prostatectomy Using National Cancer Institute Expanded Common Toxicity CriteriaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Prospective Assessment of Gastrointestinal and Genitourinary Toxicity of Salvage Radiotherapy for Patients With Prostate-Specific Antigen Relapse or Local Recurrence After Radical ProstatectomyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical ProstatectomyJournal of Clinical Oncology, 2007
- Toxicity following high‐dose salvage radiotherapy after radical prostatectomyBJU International, 2007